West Nile virus in blood: Stability, distribution, and susceptibility to PEN110 inactivation

Thomas Mather, Tsutomu Takeda, Jodie Tassello, Asa Ohagen, Diana Serebryanik, Ed Kramer, Fred Brown, Robert Tesh, Bernadette Alford, John Chapman, Aris Lazo

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

BACKGROUND: The outbreak of West Nile virus (WNV) is the most recent reminder that the blood supply continues to be vulnerable to emerging and reemerging pathogens. A potentially prospective approach to reducing the risk of transfusion-transmitted infections of a known or newly emerging microbe is implementation of a broad-spectrum pathogen reduction technology. The purpose of this study was to evaluate the susceptibility of WNV to PEN110 inactivation in RBCs and to characterize the WNV interaction with blood, including the stability of WNV in RBCs stored at 1 to 6°C, its distribution and infectivity, and its ability to infect WBCs. STUDY DESIGN AND METHODS: Inactivation was performed with three WNV isolates spiked into WBC-reduced RBCs. The stability of the virus was evaluated by spiking two viral loads into RBCs followed by storing at 1 to 6°C for up to 42 days. The distribution of the virus in plasma, RBCs, and PBMCs was evaluated with whole blood from infected hamsters. Finally, in vitro propagation of WNV was evaluated with the THP-1 cell line and primary monocytes. RESULTS: The kinetics of PEN110 inactivation of WNV isolates RI-44, NJ-176, and 99-3494031 were fast and complete within 24 hours with reduction factors of 5 to 7 log plaque-forming units per mL. WNV remained infectious for up to 42 days at 1 to 6°C. The WNV titers in whole blood, plasma, RBCs, and PBMC fractions were equally distributed and ranged from 2 to 3 log tissue culture infectious dose 50 percent per mL. Productive infection of stimulated monocytes and THP-1 cells was also demonstrated. CONCLUSIONS: These studies demonstrated that PEN110 efficiently inactivated WNV in RBCs and whole blood from infected hamsters to the limit of detection. WNV survived in RBCs stored at 1 to 6°C with a gradual loss of titer but infectivity could still be observed for up to 42 days. In addition, it was observed that WNV was equally distributed in all blood fractions including PBMCs and it was possible to establish productive infection of a human monocytic cell line and stimulated human monocytes.

Original languageEnglish (US)
Pages (from-to)1029-1037
Number of pages9
JournalTransfusion
Volume43
Issue number8
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

Fingerprint

West Nile virus
Monocytes
Viral Load
Cricetinae
PEN 110
Infection
Viruses
Cell Line
Disease Outbreaks
Limit of Detection

ASJC Scopus subject areas

  • Hematology
  • Immunology

Cite this

Mather, T., Takeda, T., Tassello, J., Ohagen, A., Serebryanik, D., Kramer, E., ... Lazo, A. (2003). West Nile virus in blood: Stability, distribution, and susceptibility to PEN110 inactivation. Transfusion, 43(8), 1029-1037. https://doi.org/10.1046/j.1537-2995.2003.00464.x

West Nile virus in blood : Stability, distribution, and susceptibility to PEN110 inactivation. / Mather, Thomas; Takeda, Tsutomu; Tassello, Jodie; Ohagen, Asa; Serebryanik, Diana; Kramer, Ed; Brown, Fred; Tesh, Robert; Alford, Bernadette; Chapman, John; Lazo, Aris.

In: Transfusion, Vol. 43, No. 8, 01.08.2003, p. 1029-1037.

Research output: Contribution to journalArticle

Mather, T, Takeda, T, Tassello, J, Ohagen, A, Serebryanik, D, Kramer, E, Brown, F, Tesh, R, Alford, B, Chapman, J & Lazo, A 2003, 'West Nile virus in blood: Stability, distribution, and susceptibility to PEN110 inactivation', Transfusion, vol. 43, no. 8, pp. 1029-1037. https://doi.org/10.1046/j.1537-2995.2003.00464.x
Mather T, Takeda T, Tassello J, Ohagen A, Serebryanik D, Kramer E et al. West Nile virus in blood: Stability, distribution, and susceptibility to PEN110 inactivation. Transfusion. 2003 Aug 1;43(8):1029-1037. https://doi.org/10.1046/j.1537-2995.2003.00464.x
Mather, Thomas ; Takeda, Tsutomu ; Tassello, Jodie ; Ohagen, Asa ; Serebryanik, Diana ; Kramer, Ed ; Brown, Fred ; Tesh, Robert ; Alford, Bernadette ; Chapman, John ; Lazo, Aris. / West Nile virus in blood : Stability, distribution, and susceptibility to PEN110 inactivation. In: Transfusion. 2003 ; Vol. 43, No. 8. pp. 1029-1037.
@article{ced5eb01462f4c9b8a5d63419908dc9d,
title = "West Nile virus in blood: Stability, distribution, and susceptibility to PEN110 inactivation",
abstract = "BACKGROUND: The outbreak of West Nile virus (WNV) is the most recent reminder that the blood supply continues to be vulnerable to emerging and reemerging pathogens. A potentially prospective approach to reducing the risk of transfusion-transmitted infections of a known or newly emerging microbe is implementation of a broad-spectrum pathogen reduction technology. The purpose of this study was to evaluate the susceptibility of WNV to PEN110 inactivation in RBCs and to characterize the WNV interaction with blood, including the stability of WNV in RBCs stored at 1 to 6°C, its distribution and infectivity, and its ability to infect WBCs. STUDY DESIGN AND METHODS: Inactivation was performed with three WNV isolates spiked into WBC-reduced RBCs. The stability of the virus was evaluated by spiking two viral loads into RBCs followed by storing at 1 to 6°C for up to 42 days. The distribution of the virus in plasma, RBCs, and PBMCs was evaluated with whole blood from infected hamsters. Finally, in vitro propagation of WNV was evaluated with the THP-1 cell line and primary monocytes. RESULTS: The kinetics of PEN110 inactivation of WNV isolates RI-44, NJ-176, and 99-3494031 were fast and complete within 24 hours with reduction factors of 5 to 7 log plaque-forming units per mL. WNV remained infectious for up to 42 days at 1 to 6°C. The WNV titers in whole blood, plasma, RBCs, and PBMC fractions were equally distributed and ranged from 2 to 3 log tissue culture infectious dose 50 percent per mL. Productive infection of stimulated monocytes and THP-1 cells was also demonstrated. CONCLUSIONS: These studies demonstrated that PEN110 efficiently inactivated WNV in RBCs and whole blood from infected hamsters to the limit of detection. WNV survived in RBCs stored at 1 to 6°C with a gradual loss of titer but infectivity could still be observed for up to 42 days. In addition, it was observed that WNV was equally distributed in all blood fractions including PBMCs and it was possible to establish productive infection of a human monocytic cell line and stimulated human monocytes.",
author = "Thomas Mather and Tsutomu Takeda and Jodie Tassello and Asa Ohagen and Diana Serebryanik and Ed Kramer and Fred Brown and Robert Tesh and Bernadette Alford and John Chapman and Aris Lazo",
year = "2003",
month = "8",
day = "1",
doi = "10.1046/j.1537-2995.2003.00464.x",
language = "English (US)",
volume = "43",
pages = "1029--1037",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - West Nile virus in blood

T2 - Stability, distribution, and susceptibility to PEN110 inactivation

AU - Mather, Thomas

AU - Takeda, Tsutomu

AU - Tassello, Jodie

AU - Ohagen, Asa

AU - Serebryanik, Diana

AU - Kramer, Ed

AU - Brown, Fred

AU - Tesh, Robert

AU - Alford, Bernadette

AU - Chapman, John

AU - Lazo, Aris

PY - 2003/8/1

Y1 - 2003/8/1

N2 - BACKGROUND: The outbreak of West Nile virus (WNV) is the most recent reminder that the blood supply continues to be vulnerable to emerging and reemerging pathogens. A potentially prospective approach to reducing the risk of transfusion-transmitted infections of a known or newly emerging microbe is implementation of a broad-spectrum pathogen reduction technology. The purpose of this study was to evaluate the susceptibility of WNV to PEN110 inactivation in RBCs and to characterize the WNV interaction with blood, including the stability of WNV in RBCs stored at 1 to 6°C, its distribution and infectivity, and its ability to infect WBCs. STUDY DESIGN AND METHODS: Inactivation was performed with three WNV isolates spiked into WBC-reduced RBCs. The stability of the virus was evaluated by spiking two viral loads into RBCs followed by storing at 1 to 6°C for up to 42 days. The distribution of the virus in plasma, RBCs, and PBMCs was evaluated with whole blood from infected hamsters. Finally, in vitro propagation of WNV was evaluated with the THP-1 cell line and primary monocytes. RESULTS: The kinetics of PEN110 inactivation of WNV isolates RI-44, NJ-176, and 99-3494031 were fast and complete within 24 hours with reduction factors of 5 to 7 log plaque-forming units per mL. WNV remained infectious for up to 42 days at 1 to 6°C. The WNV titers in whole blood, plasma, RBCs, and PBMC fractions were equally distributed and ranged from 2 to 3 log tissue culture infectious dose 50 percent per mL. Productive infection of stimulated monocytes and THP-1 cells was also demonstrated. CONCLUSIONS: These studies demonstrated that PEN110 efficiently inactivated WNV in RBCs and whole blood from infected hamsters to the limit of detection. WNV survived in RBCs stored at 1 to 6°C with a gradual loss of titer but infectivity could still be observed for up to 42 days. In addition, it was observed that WNV was equally distributed in all blood fractions including PBMCs and it was possible to establish productive infection of a human monocytic cell line and stimulated human monocytes.

AB - BACKGROUND: The outbreak of West Nile virus (WNV) is the most recent reminder that the blood supply continues to be vulnerable to emerging and reemerging pathogens. A potentially prospective approach to reducing the risk of transfusion-transmitted infections of a known or newly emerging microbe is implementation of a broad-spectrum pathogen reduction technology. The purpose of this study was to evaluate the susceptibility of WNV to PEN110 inactivation in RBCs and to characterize the WNV interaction with blood, including the stability of WNV in RBCs stored at 1 to 6°C, its distribution and infectivity, and its ability to infect WBCs. STUDY DESIGN AND METHODS: Inactivation was performed with three WNV isolates spiked into WBC-reduced RBCs. The stability of the virus was evaluated by spiking two viral loads into RBCs followed by storing at 1 to 6°C for up to 42 days. The distribution of the virus in plasma, RBCs, and PBMCs was evaluated with whole blood from infected hamsters. Finally, in vitro propagation of WNV was evaluated with the THP-1 cell line and primary monocytes. RESULTS: The kinetics of PEN110 inactivation of WNV isolates RI-44, NJ-176, and 99-3494031 were fast and complete within 24 hours with reduction factors of 5 to 7 log plaque-forming units per mL. WNV remained infectious for up to 42 days at 1 to 6°C. The WNV titers in whole blood, plasma, RBCs, and PBMC fractions were equally distributed and ranged from 2 to 3 log tissue culture infectious dose 50 percent per mL. Productive infection of stimulated monocytes and THP-1 cells was also demonstrated. CONCLUSIONS: These studies demonstrated that PEN110 efficiently inactivated WNV in RBCs and whole blood from infected hamsters to the limit of detection. WNV survived in RBCs stored at 1 to 6°C with a gradual loss of titer but infectivity could still be observed for up to 42 days. In addition, it was observed that WNV was equally distributed in all blood fractions including PBMCs and it was possible to establish productive infection of a human monocytic cell line and stimulated human monocytes.

UR - http://www.scopus.com/inward/record.url?scp=0041428185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041428185&partnerID=8YFLogxK

U2 - 10.1046/j.1537-2995.2003.00464.x

DO - 10.1046/j.1537-2995.2003.00464.x

M3 - Article

C2 - 12869107

AN - SCOPUS:0041428185

VL - 43

SP - 1029

EP - 1037

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 8

ER -